Back to search
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Biochemical Recurrence of Malignant Neoplasm of Prostate trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Biochemical Recurrence of Malignant Neoplasm of Prostate trials you may qualify forBackground: Prostate cancer is the second leading cause of cancer-related death in American men. The disease recurs in up to 50,000 men each year after their e…
TerbinaPro is a phase II drug-repurposing study evaluating oral Terbinafine in patients with biochemical recurrence of prostate cancer after prior local treatme…
The aim of this registry study with long-term follow-up is to record the course of therapy and disease in patients with recurrent and metastatic prostate cancer…
This is a multi-center clinical study enrolling up to 10 participants. The purpose of this study is to assess the feasibility and safety of intratumoral DaRT se…
The REFINE study is evaluating whether a fluciclovine (18F) PET/CT scan can detect recurrent prostate cancer in patients whose previous PSMA PET/CT was negative…
This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer in…
This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer. The drug involved in this study is: -Nivolumab
Main Study: The purpose of main study is to assess if the combination of apalutamide and androgen deprivation therapy (ADT) in participants with high-risk local…
In this observational study, participants receive darolutamide: a treatment that is already available for doctors to prescribe for non-metastatic castration-res…